Skip to main content
. 2017 Nov 27;12(11):e0188120. doi: 10.1371/journal.pone.0188120

Table 4. Demographic characteristics, risk factors and overall cancer prevalence in different clusters of DMT.

SEM: Standard error of the mean. IM: immunomodulatory disease modifying treatments; IS: Immunosuppressant disease modifying treatments.

IM only
(n = 465)
IS only
(n = 114)
IM and IS
(n = 229)
None
(n = 264)
p
Age: mean ± SEM 47.1 ± 0.5 56.5 ± 1.2 49.0 ± 0.8 55.6 ± 0.8 <0.001
Female gender: % (n) 78.7 (366) 75.4 (86) 80.8 (185) 79.6 (210) 0.71
History of tobacco smoking: % (n) 53.6 (249) 38.6 (44) 52.8 (121) 46.6 (123) 0.02
History of alcohol consumption: % (n) 10.3 (48) 7.9 (9) 7.9 (18) 14.39 (38) 0.08
Overall cancer prevalence: % (n) 5.59 (26) 6.14 (7) 3.93 (9) 7.20 (19) 0.48